News – Page 435 – Endpoints News

Seagen touts progress for Padcev and Tukysa as it continues CEO search

3 years ago

Gilead's $1.7B hep D drug just ran into a roadblock at the FDA

3 years ago

Bristol Myers expands cancer survivor campaign with actor and spokesperson Sterling K. Brown

3 years ago

FDA raises efficacy concerns with Y-mAbs' potential therapy for pediatric neuroblastoma ahead of ODAC meeting

3 years ago

Merck CEO Rob Davis has business development on the brain as he builds 'pipeline of the future'

3 years ago

In next step of opioid saga, McKinsey reaches proposed agreement with school districts and local governments

3 years ago

Manufacturing roundup: Symeres buys CRO in New Jersey; Cambrex invests $16M+ in Minnesota and Iowa facilities

3 years ago

GSK puts a 'force majeure’ on the manufacturing of a pain medicine in Pakistan

3 years ago

Broad and MIT scientists repurpose hot RNA editing tech as ‘radar’ with uses in cancer and brain research

3 years ago

Alnylam blames the Inflation Reduction Act for a PhIII cut — would it have sold enough for negotiations?

3 years ago

Plant-based Covid-19 vaccine developer Medicago laying off 60+ at North Carolina plant

3 years ago

2seventy inks T cell partnership with Chinese biotech; Antisense drug causes brain side effect — report

3 years ago

AstraZeneca's Ultomiris reduces episode occurrence in NMOSD, meeting primary and secondary endpoints

3 years ago

Eli Lilly commits $92M+ to Purdue University to establish pharma manufacturing scholarship program

3 years ago

Takeda bumps Entyvio peak sales, lays out dengue vaccine plans and celiac pipeline in latest earnings call

3 years ago

Fujifilm Diosynth breaks ground on $300M expansion project in Texas

3 years ago

Moderna nearing deal with US government to develop Ebola vaccines — report

3 years ago

‘Unlikely to transform patient care’: GSK punts top late-stage drug after PhIII data disappoint

3 years ago

Adcomm offers mixed vote, recommends GSK's kidney disease drug in just one patient population

3 years ago

'Beginning of a broader loss': Pharma execs call regulators and legislators to action four months post-Roe

3 years ago

Indian site for Jubilant Generics lands Form 483 for QC issues

3 years ago

Emergency clinical research: Biden's OSTP wants to settle 'key terms' in advance of trials

3 years ago

As Revlimid faces more competition, Bristol Myers' goal is to 'grow the company'

3 years ago

Aurobindo Pharma’s US branch issues a recall of a generic medicine

3 years ago

First page Previous page 432 433 434435436 437 438 Next page Last page